Skip to content

Effect of Intraoperative Crystalloid Volume on Postoperative Vomiting

Effect of Intravenous Crystalloid Volume on Postoperative Nausea and Vomiting After Tonsillectomy and/or Adenoidectomy: a Prospective, Randomized, Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02177201
Acronym
EICVPV
Enrollment
160
Registered
2014-06-27
Start date
2013-08-31
Completion date
2014-08-31
Last updated
2016-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Vomiting

Brief summary

Postoperative nausea and vomiting is very common in children undergone tonsillectomy and/or adenoidectomy. The purpose of this clinical trial is to evaluate the antiemetic effect of super-hydration with 0.9% saline in children undergoing specifically elective otorhinolaryngological surgery. Fluid intake reduces vomiting as seen following extended period of fasting that interrupts the perfusion in gut. Based on this knowledge, we hypothesized that administration of supplemental fluid would reduce the incidence of postoperative vomiting.

Detailed description

At the initiation of the study, 160 patients we enrolled consecutively . Six of the patients were excluded according to the inclusion/exclusion criteria. Remaining one hundred fifty four were American Society of Anesthesia (ASA) I-II classified children , aged 2-15 yr, undergoing elective tonsillectomy, with or without adenoidectomy, under general anesthesia . Induction and maintenance of anesthesia were standardized with fentanyl, lidocaine, rocuronium and sevoflurane in nitrous oxide (N(2)O). Subjects were assigned to two groups administered with saline solution (%0.9 saline) at different rates; either 10 ml/kg/h or 20ml/kg/h delivery arms.

Interventions

OTHERGroup 1

Intravenous access was established and 10 ml/kg/h 0.9% saline solution was delivered following the induction of anesthesia and until the end of the operation.

OTHERGroup 2

Intravenous access was established and 20 ml/kg/h 0.9% saline solution was delivered following the induction of anesthesia and until the end of the operation.

Sponsors

Aydin Adnan Menderes University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
2 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

ASA physical status I or II * Age 2-15 yr * Scheduled for elective tonsillectomy and/or adenotonsillectomy

Exclusion criteria

* History of diabetes * History of mental retardation * Obesity (BMI = \> 95th percentile for age and sex) * Intake of antiemetic or psychoactive medication within 24 hours before surgery * Known gastroesophageal reflux

Design outcomes

Primary

MeasureTime frameDescription
Postoperative VomitingFirst 24 hours postoperativePresence of at least one episode of vomiting within the first 24 hours of postoperative is positive for definition

Countries

Turkey (Türkiye)

Participant flow

Participants by arm

ArmCount
Group 1
Intravenous 10 ml/kg/h 0.9% saline solution
80
Group 2
Intravenous 20 ml/kg/h 0.9% saline solution
80
Total160

Baseline characteristics

CharacteristicGroup 2TotalGroup 1
Age, Categorical
<=18 years
80 Participants160 Participants80 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Region of Enrollment
Turkey
80 participants160 participants80 participants
Sex: Female, Male
Female
40 Participants80 Participants40 Participants
Sex: Female, Male
Male
40 Participants80 Participants40 Participants
Supplemental fluid administration for vomiting80 participants160 participants80 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 770 / 77
serious
Total, serious adverse events
0 / 770 / 77

Outcome results

Primary

Postoperative Vomiting

Presence of at least one episode of vomiting within the first 24 hours of postoperative is positive for definition

Time frame: First 24 hours postoperative

ArmMeasureGroupValue (NUMBER)
10 ml/kg/h 0.9 %Saline SolutionPostoperative Vomitingvomiting11 participants
10 ml/kg/h 0.9 %Saline SolutionPostoperative Vomitingnot vomiting66 participants
20 ml/kg/h 0.9% Saline SolutionPostoperative Vomitingvomiting9 participants
20 ml/kg/h 0.9% Saline SolutionPostoperative Vomitingnot vomiting68 participants
Comparison: Null hypothesis: The antiemetic effect was not significantly different for two groups in this studyp-value: 0.05t-test, 2 sided
Comparison: 77 patients was needed in each groups for an 20% effect size, 5% alpha and 80% statistical power for postoperative vomiting.p-value: <0.05Chi-squared, Corrected

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026